At Collegium Pharmaceutical, we are building a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. We have a portfolio of meaningfully differentiated medications to treat serious medical conditions, including moderate-to-severe pain and acute migraine.
The Vice President, Regulatory Affairs will be responsible for providing regulatory leadership for our organization and products, which includes leading the regulatory team. As a leader, role model, and mentor within the company, he/she will ensure all regulatory deliverables across programs are completed according to timelines, budget, operational procedures, regulations, International Council for Harmonisation-Good Clinical Practice (ICH-GCP) guidelines, and quality standards. He/she will also be required to be “hands-on” as we celebrate teamwork in execution of our objectives and goals across our company.
Persons applying for employment with Collegium Pharmaceutical on and after August 1, 2021, who are offered a position are expected to be able to provide proof of vaccination against COVID-19 prior to their start date as permitted under state law, unless they seek and are approved for an exemption by Collegium as a reasonable accommodation based on bona fide religious or medical grounds.
assessing regulatory categorization of adverse events reported during use in the population and assist Pharmacovigilance in the preparation and filing of expedited safety and periodic safety reports to FDA, as necessary.
Software Powered by iCIMS
www.icims.com